Annette North, EVP, General Counsel & Secty at Turning Point Therapeutics, Inc. (TPTX), sold 27,300 shares at $75.94 ($2.1M) on 2021-06-15, disclosed to the SEC on 2021-06-16.
Open-market sale of $2.1M TPTX by EVP, General Counsel & Secty. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.94 | 5,666 | $430K | 20.5% |
| 2 | $75.94 | 5,666 | $430K | 20.5% |
| 3 | $77.37 | 2,700 | $209K | 9.9% |
| 4 | $77.82 | 6,634 | $516K | 24.6% |
| 5 | $77.82 | 6,634 | $516K | 24.6% |
| Total | $77.00 avg | 27,300 |
| $2.1M |
| 100% |
| Filing → |
| TPTX | SELL | 2021-03-09 | $4.3M | — | Filing → |
| TPTX | SELL | 2021-02-02 | $5.7M | — | Filing → |